Sprout Pharmaceuticals Revenue and Competitors

Claim your profile

Location

$104.3M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Sprout Pharmaceuticals's estimated annual revenue is currently $5.5M per year.(i)
  • Sprout Pharmaceuticals's estimated revenue per employee is $100,500
  • Sprout Pharmaceuticals's total funding is $104.3M.

Employee Data

  • Sprout Pharmaceuticals has 55 Employees.(i)
  • Sprout Pharmaceuticals grew their employee count by -4% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.1M25-7%N/AN/A
#2
$3.2M160%N/AN/A
#3
$67.1M3346%N/AN/A
#4
$25.5M12755%N/AN/A
#5
$72.6M28928%$35MN/A
#6
$3.3M4048%N/AN/A
#7
$3.1M38-25%N/AN/A
#8
$165.7M21614%$250.7MN/A
#9
$22.3M1114%$637.8KN/A
#10
$44M2198%N/AN/A

We're committed to breakthrough firsts in women's sexual health. Novel ideas fuel our entrepreneurial passion. At Sprout, we celebrate ownership, boldness, quirkiness, learning, family and appreciation. They are central to what we stand for and what we're trying to collectively accomplish.

keywords:Biotechnology,Healthcare,Pharmaceuticals

$104.3M

Total Funding

55

Number of Employees

$5.5M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sprout Pharmaceuticals News

2022-04-20 - Cytovia Goes Public in SPAC Deal Amidst Slow Biotech IPO ...

... and Bob Whitehead, a long-standing pharmaceutical executive, co-founder and CEO of Sprout Pharmaceuticals and Slate Pharmaceuticals.

2022-04-19 - Female Sexual Dysfunction Treatment Market Size, Scope ...

... Treatment Market Size, Scope And Outlook | AMAG Pharmaceuticals Inc., Duchesnay Inc., Emotional Brain BV, Novo Nordisk AS, Sprout Pharmaceuticals Inc.

2022-04-17 - Sexual Health Market accounted for US$ 14.1 Billion and is ...

Following the acquisition of Sprout Pharmaceuticals, Inc., ... in the sexual health market include Teva Pharmaceutical Industries Ltd.,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.2M5541%N/A
#2
$7.5M55-8%N/A
#3
$7.5M5531%N/A
#4
$7.4M5534%N/A
#5
$12.2M55-23%N/A